A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry

Background: Growing evidence has confirmed that populations with type 2 diabetes mellitus (T2DM) have an increasing risk of developing colorectal cancer (CRC). Thus, convenient and effective screening strategies for CRC should be developed for the T2DM population to increase the detection rate of CR...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jiayue Yang, Weigang Fang, Wenjun Wu, Zhen Tian, Rong Gao, Lu Yu, Dayang Chen, Xiaohua Weng, Shengwei Zhu, Cheng Yang
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
PZP
Accès en ligne:https://doaj.org/article/7b7d3051e1494d88a55880349c2c8e84
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!